InvestorsHub Logo
Followers 832
Posts 119983
Boards Moderated 17
Alias Born 09/05/2002

Re: biotech_researcher post# 301

Thursday, 11/30/2017 6:30:06 PM

Thursday, November 30, 2017 6:30:06 PM

Post# of 7826
RVNC advances cervical-dystonia program to phase-3 (11/29/17 PR):

http://investors.revance.com/releasedetail.cfm?ReleaseID=1050212

A single global phase-3 program will be conducted to satisfy both the FDA and EMA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News